Why Do Discontinued Drugs Still Appear in Medical Charts?

-



Why Do Discontinued Drugs Still Appear in Medical Charts?

Many medical coders would have crossed a situation where the drug prescribed in medical charts is shown as “discontinued” in FDA records. At that moment, we wonder: should we code for this drug or not? What does “discontinued” really mean?

This is a common confusion in healthcare documentation, and the answer lies in understanding how the FDA uses the term “discontinued” — and why it doesn’t always mean “banned.”

What “Discontinued” Means in FDA Records

  • Business Decisions: A manufacturer may stop producing a drug due to low demand, competition, or cost. This does not mean the drug is unsafe.
  • Market Withdrawal: Sometimes a brand name is discontinued, but generic versions remain FDA‑approved and available.
  • Regulatory Updates: A drug may be discontinued if it no longer meets updated FDA requirements, even if it was safe when first approved.
  • Reclassification: Certain drugs are discontinued as prescription items but reclassified as over‑the‑counter (OTC).

So, “discontinued” often reflects availability in the market, not necessarily safety status.

Why They Still Appear in Medical Charts

  • Legacy Prescriptions: Patients who were stable on a discontinued brand may continue with generics or leftover stock.
  • Generic Equivalents: Even if the brand is gone, generics remain in use and show up in medical records.
  • EHR Databases: Electronic health record systems often retain discontinued drugs in their lists, so they appear in charts even if no longer marketed.
  • International Supply: Some drugs discontinued in the U.S. may still be available abroad, and imported versions can be prescribed.
  • Special Access Programs: In rare cases, discontinued drugs may be used under compassionate use or special access when alternatives are limited.

Coding Perspective

For coders, the key is to distinguish between:

  • Discontinued for business reasons → still valid to code if prescribed, especially when generics exist.
  • Withdrawn for safety reasons → should be flagged, as coding such drugs may raise compliance issues.

Always check whether the drug is truly withdrawn for safety or simply discontinued from the market. Coding should reflect what is documented in the chart, but awareness of FDA status helps ensure accuracy and compliance.

Conclusion

A “discontinued” label in FDA records does not always mean a drug is banned or unsafe. More often, it reflects market withdrawal, manufacturer decisions, or regulatory changes. That’s why you may still see these drugs in medical charts — through generics, legacy prescriptions, or EHR databases.

For medical coders, the safest approach is to code what is documented, but also stay alert to whether the drug was discontinued for safety reasons. This awareness bridges the gap between regulatory data and real‑world practice, ensuring both accuracy and patient safety.

Comments

Post a Comment

Popular posts from this blog

E/M Coding MDM Clarification: Lab Ordered and Reviewed — One Point or Two?

-
Image
E/M Coding MDM Clarification: Lab Ordered and Reviewed — One Point or Two? Medical coders often struggle with the Medical Decision Making (MDM) data table in E/M coding. One of the most debated points is: If a lab test is both ordered and reviewed, does it count as one point or two? MDM scoring determines the level of service — and over‑counting can lead to upcoding risks , while under‑counting can reduce legitimate reimbursement. Let's see how to calculate this and the supporting guidelines. The AMA CPT E/M Guidelines AMA Guideline states: “Tests are counted once per unique test, even if ordered and reviewed. Ordering and reviewing the same test is not counted separately.” CBC ordered and reviewed → 1 point CBC ordered + X‑ray ordered and reviewed → 2 points (one for each unique test) CBC ordered + external lab report reviewed (from another provider) → 2 points (because external data review is a separate element) Why Double‑Counting Is Risky Considering ...
Read more

Pregnancy Coding in Ancillary Charts: The Z3A.00 Confusion

-
Image
Pregnancy Coding in Ancillary Charts: The Z3A.00 Confusion Introduction Medical coders working in ancillary specialties often face unique challenges due to limited documentation. In many cases, coders only have access to the physician’s order and order plan. This becomes particularly complex when coding pregnancy charts, where gestational weeks are often missing. One common question arises: Can we assign Z3A.00 (weeks of gestation not specified) when no weeks are documented? General Guideline on Z3A Codes According to ICD-10-CM Official Guidelines: Z3A.xx codes (weeks of gestation) must be supported by documentation of the exact week. Z3A.00 is used only when the provider explicitly documents “unknown gestational age.” If weeks are not documented at all, no Z3A code should be assigned . In short, absence of documentation does not equal “unknown gestational age.” It simply means the coder should not assign Z3A. Why Clients Ask for Z3A.00 De...
Read more

Predicting Human Lifespan Using Healthcare Data Analytics: Can Ayurveda Add a New Dimension?

-
Image
Predicting Human Lifespan Using Healthcare Data Analytics: Can Ayurveda Add a New Dimension? Introduction Predicting human lifespan has always been a challenging yet fascinating goal in healthcare. With the rise of data science, predictive models are now used to estimate survival probabilities based on clinical and demographic data. However, most existing models rely purely on biomedical factors and often overlook deeper individualized and environmental influences. This article explores a unique and innovative idea: integrating Ayurvedic principles such as dosha (body constitution) and desha (geographical influence) into modern predictive analytics to improve lifespan prediction. Current Approach in Healthcare Data Analytics Modern prediction of survival is primarily done using techniques from Survival Analysis. These models do not predict exact lifespan but estimate probabilities such as: Risk of mortality within a specific time (e.g., 1 year, 5 years) Su...
Read more